In our last issue, Steven Kelman of Harvard’s Kennedy School of Government criticized cost-benefit analysis from the perspective not of economics but of ethical theory. He concluded that in health, ...
The cost avoidance of heart failure–related hospitalizations and emergency department visits may outweigh the additional drug cost in Medicaid members adherent to sacubitril/valsartan. Objective: To ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results